Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chiesi Farmaceutici S.p.A.
A randomised, double-blind, multinational, multicentre, active-controlled, 3-way cross-over study to evaluate the effect on trough FEV1 after 4 weeks treatment with CHF5188 pMDI qd in adult patients with moderate or severe persistent asthma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Moderate or severe asthma partly controlled with ICS or ICS/LABA
FEV1 ≥ 60% and ≤ 90% of predicted for the patient normal value
You may not be if
Diagnosis of COPD
History or current evidence of significant cardiovascular disease